# Furosemide in Early Acute Kidney Injury

> **NCT00978354** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Alberta** · enrollment: 72 (actual)

## Conditions studied

- Acute Renal Failure

## Interventions

- **DRUG:** Furosemide
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT00978354
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 72 (ACTUAL)
- **Why stopped:** Feasibility of target enrollment within the context of available funding resources.
- **Last updated:** 2015-09-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978354, "Furosemide in Early Acute Kidney Injury". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00978354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*